BiotechTube
Home/H.U. Group Holdings/Mikio Ishizuka
MI

Mikio Ishizuka

Representative Director, President & CEO

H.U. Group Holdings

Therapeutic Areas

OncologyNeurologyInfectious DiseaseGeneral Health Screening

H.U. Group Holdings Pipeline

DrugIndicationPhase
Blood-based p-tau/Aβ AssaysAlzheimer's Disease Diagnosis & MonitoringCommercial
Novel Cancer Biomarkers (e.g., Autoantibodies)Various Cancers (Pancreatic, Ovarian)Development & Validation
HE4 Tumor MarkerOvarian Cancer MonitoringCommercial
Infectious Disease AssaysEmerging Pathogens (e.g., SARS-CoV-2)Continuous Development
Digital Pathology & AI ToolsOncology HistopathologyDevelopment

Leadership Team at H.U. Group Holdings

SN
Shuji Nakamura
Director, Senior Managing Executive Officer
HO
Hiroshi Ozeki
Director, Senior Managing Executive Officer
YT
Yoshihiko Tagawa
Director, Managing Executive Officer
KO
Kunio Ohyama
Director
View full H.U. Group Holdings profile